1 September 2010 CURRICULUM VITAE NAME: Richard I. Fisher ...

1

September 2010 CURRICULUM VITAE NAME: Richard I. Fisher, M.D. MARRIED: Susan Gross Fisher, Ph.D. Professor and Chair (with unlimited tenure) Department of Community and Preventative Medicine University of Rochester CHILDREN: Jonathan Ryan Fisher, 3/27/74, B.A., University of Wisconsin Caroline Gross Fisher, 7/27/82, B.A., Magna cum laude, Harvard College, ‘04

Courtney Gross Fisher, 10/1/86, Cornell University EDUCATION: 1963-1966 Harvard College; Major-chemistry and physics 1966-1970, M.D. Harvard Medical School-graduate Cum Laude POSITIONS HELD: 1970-1971 Internship

Massachusetts General Hospital Boston, Massachusetts

1971-1972 Assistant Resident in Medicine

Massachusetts General Hospital Boston, Massachusetts

1972-1974 Clinical Associate

Immunology Branch National Cancer Institute (Public Health Service) Bethesda, Maryland

1974-1975 Oncology Fellowship

Medicine Branch National Cancer Institute Bethesda, Maryland

1975-1984 Senior Investigator and Attending Physician

Medicine Branch National Cancer Institute Bethesda, Maryland

1984-2001 Professor of Medicine

Loyola University Stritch School of Medicine Maywood, Illinois

1984-2001 Dorothy W. and J.D. Stetson Coleman Professor of Oncology

2


1984-2001 Program Director, Section of Hematology/Oncology, Hines Veterans

Administration Hospital Hines, Illinois

1984-1992 Chief, Section of Hematology/Oncology


1992-2001 Director, Division of Hematology/Oncology


1984-1994 Director, Oncology Institute


1994-1996 Director, Loyola University Cancer Center


1996-2001 Director, Cardinal Bernardin Cancer Center


2001-Present Samuel E. Durand Professor of Medicine

University of Rochester School of Medicine & Dentistry Rochester, New York

2001-2009 Director, Hematology/Oncology Division


2001-Present Director of Cancer Services

Strong Health System Rochester, New York

2001-Present Director, James P. Wilmot Cancer Center


2007-Present Vice President

University of Rochester Medical Center 2008-Present Senior Associate Dean for Clinical Affairs University of Rochester School of Medicine & Dentistry 2008-Present Director University of Rochester Medical Faculty Group (URMFG)

3

MEDICAL CERTIFICATION Diplomate, National Board of Medical Examiners, July, 1971 Diplomate, American Board of Internal Medicine, June, 1973 Diplomate, Subspecialty of Oncology, American Board of Internal Medicine, October, 1977 SOCIETIES American Society of Clinical Oncology American Association for Cancer Research American Society of Hematology European Society for Medical Oncology American Association of Immunologists American College of Physicians Central Society for Clinical Research Clinical Immunology Society Chicago Society of Internal Medicine American Medical Association Illinois State Medical Society Chicago Medical Society American College of Physician Executives Association of Subspecialty Professors NATIONAL COMMITTEES 1975-1979 Combined Modality Committee, Division of Cancer Treatment, National

Cancer Institute, Bethesda, Maryland 1983 Phase II Biologic Response Modifiers Review Committee 1985-1991 Industry (Exhibits) Advisory Committee, American Society of Clinical

Oncology 1985-2001 Principal Investigator, Loyola University for the Southwest Oncology Group 1986-1988 Medical Research Advisory Group A, Veterans Administration Central

Office 1989 Chairman, Ad Hoc Committee on Pharmaceutical Funding, American

Society of Clinical Oncology 1988-1992 Young Investigators' Award Committee, American Society of Clinical

Oncology 1988-1994 Editor, Newsletter, American Society of Clinical Oncology 1988-1992 Physician Advisory Board, Cetus Corporation 1989 Physician Advisory Board, Schering-Plough/Sandoz Corporation

4

1990 Vitamin C History Review, National Cancer Institute 1991-1992 National Cancer Institute PO-1 Site Visit and Reverse Site Visit Team for

University of Arkansas 1992-1993 Oncology Advisory Board, Adria Laboratories 1992-1994 Chairman, Cytokine Advisory Board, Sandoz Pharmaceuticals Corporation 1992 NIH Site Visit Team for Cancer & Leukemia Group B 1992-1995 Genetics Institute IL-11 Medical Advisory Board 1993 NIH PO-1 Site Visit Team for National Bone Marrow Transplant Registry 1993-2001 Midwest Cancer Directors Council 1993-1995 Ortho Biotech Development Panel 1994 NIH PO-1 Site Visit Team for Stanford University Lymphoma Program 1997 NIH Site Visit Team for Cancer & Leukemia Group B 1998 NIH Site Visit Team for Eastern Cooperative Oncology Group 1999 NIH Site Visit Team for American College of Surgeons Oncology Group 1999-2001 American Joint Committee on Cancer’s Lymphoma Task Force 2000 NIH Site Visit Team for North Central Cancer Treatment Group 2002 Genta Advisory Board 2002-Present Policy and Planning Committee, Association of American Cancer Institutes 2002-Present ASCO Hematology-Oncology Task Force 2003 Seattle Genetics Advisory Board 2002-Present Principal Investigator University of Rochester Membership in Southwest

Oncology Group 2003 Ligand Group Advisory Board 2003-Present Member, Board of Scientific Advisors, V (Jim Valvano) Foundation 2005 Ad Hoc Member, NIH Clinical Oncology Study Section 2006 Ad Hoc Member, Dana-Farber Cancer Institute External Advisory Board 2008 NCI Site Visit Team, Medical University of South Carolina Cancer Center

5

2009 - Present Member, NCI Lymphoma Steering Committee 2010 NCI Site Visit Team, University of Pittsburgh Cancer Center 2010 Ad Hoc Member, NCI Cancer Centers Parent Committee 2010 NCI Site Visit Team, Norris Cancer Center, University of Southern California INTERNATIONAL COMMITTEES 1994 - Present Member, Scientific Committee/Advisory Board, International Symposiums

on Hodgkin’s disease. (Held every three years in Cologne, Germany) Professor Volker Diehl, Chairman

1997 – 2003 Advisory Board for International Conferences on Malignant

Lymphoma. (Held every three years in Lugano, Switzerland) Professor Franco Cavalli, Chairman

1998 - Present Member, Scientific Advisory Board, 2nd International Symposium on

Malignant Lymphomas. Professor W. Hiddeman and H. Stein, Chairmen 2005 - Present Reviewer, United Kingdom Lymphoma Clinical Trials Group LOCAL COMMITTEES 1984-1992 Board of Trustees and Executive Committee, Illinois Cancer Council 1984-1996 Research Committee of the Council, Loyola University Medical School 1985 Department of Pathology Chairman Search Committee, Loyola University

Medical School 1986-1992 Committee on Academic Rank and Tenure, Loyola University Medical

School 1990 Department of Medicine Chairman Search Committee, Loyola University

Medical School 1991-1992 M.D. /Ph.D. Steering Committee, Loyola University Medical School 1993-1994 Co-Chairman, Clinical Programs Task Force, Loyola University Medical

School 1994 Liaison Committee on Medical Education, Research Subcommittee, Loyola

University Medical Center 1994 Co-Chairman, Marketing Steering Committee, Loyola University Medical

Center

6

1994-1995 Chairman, Radiotherapy Chairman Search Committee, Loyola University Medical Center

1994-1996 Operations Restructuring/Clinical Resource Management Steering

Committee, Loyola University Medical Center 1995-2001 Dean's Executive Faculty Group, Loyola University Stritch School of

Medicine 1996 Steering Committee for Strategic Planning Effort, Loyola University

Stritch School of Medicine 1996-1999 Research Advisory Council, Research Program Line, LUSSOM 1997-1999 Finance Committee, Loyola University Physician’s Foundation 1998 Women’s Health Service Line Steering Committee 1998 Search Committee for Dean of Stritch School of Medicine 1999-2001 Research & Patent Policy/Technology Transfer Committee, LUSSOM 2000 Ad hoc Committee, Future of Research at LUSSOM 2000 Self-Study Task Force and Objectives/Governance/Administration

Committees, LCME 2000-2001 Stritch School of Medicine Medical Council 2001-Present Medical School Advisory Council (MEDSAC), University of Rochester 2001-Present Clinical Chairs/Chiefs-Medical Staff, University of Rochester 2001-2003 Informal Executive Committee, University of Rochester 2002 Task Force on Physical Medicine and Rehabilitation, University of Rochester 2002-2005 MEDSAC Steering Committee, University of Rochester

(Promotion and Tenure Committee) 2003 Research Task Force, University of Rochester Strategic Planning Process 2003 Clinical Task Force, University of Rochester Strategic Planning Process 2003 Search Committee for Chair of Department of Surgery 2003 Chair, Search Committee for Chair of Department of Pathology 2003-2006 Primary Advisory, M.D. /Ph.D. Program 2003-2006 University of Rochester Medical Center Executive Committee

7

2004-Present Executive Committee University of Rochester Medical Faculty Group 2004 Chair, Research Stabilization Reserve Oversight Committee, University of Rochester Medical Center 2005-Present Scientific Advisory Committee, Office of Corporate Alliances, University of

Rochester Medical Center 2005-Present Director, Wilmot Cancer Research Fellowship Program 2006- Present Clinical CEO Advisory Group (C-CARG) 2006-Present Research CEO Advisory Group (R-CARG) 2007-Present Clinical Subcommittee on Quality, Safety and Patient Satisfaction 2007-Present University of Rochester Medical Center Board 2007- Present University of Rochester Medical Center Leadership Team 2007-Present University of Rochester Medical Center Executive Team LICENSED TO PRACTICE MEDICINE: Massachusetts, New York (Illinois-inactive 08/01/02) OTHER ACTIVITIES 1975-1982 Project Officer, W.H.O. Collaborating Centers for Evaluation of Methods of

Diagnosis and Treatment of Melanoma 1980 Chairman, Non-Hodgkin's Lymphoma Scientific Session, American Society

of Clinical Oncology Annual Meeting 1982 Consultant, Lymphoma Panel, Southwest Oncology Group 1983 Chairman, Non-Hodgkin's Lymphoma Educational Sessions, American

Society of Hematology 1984 Chairman, Hodgkin's Disease Scientific Session, American Society of

Clinical Oncology Annual Meeting 1987 Presenter, Plenary Session, American Society of Clinical Oncology Annual

Meeting 1988 Chairman, Biologic Response Modifiers Education Session, American

Society of Clinical Oncology Annual Meeting 1989 Chairman, Adult lymphoma and Myeloma Scientific Session, American

Society of Clinical Oncology Annual Meeting

8

1991 Chairman, Cetus Corporation's presentation of Interleukin-2 to FDA

Advisory Committee 1992 Presenter, Plenary Session, American Society of Clinical Oncology Meeting 1992 Reviewer, Lymphoma and Plasma Cell Dyscrasia Abstracts, American

Society of Hematology Annual Meeting 1992 Chairman, Lymphoma and Myeloma Therapy Session, American Society of

Hematology Annual Meeting 1993 Presenter, Non-Hodgkin's Lymphoma Education Session, American Society

of Clinical Oncology Annual Meeting 1993 Chairman, Interleukin-2: Advances in Clinical Research and Treatment,

National Investigators Meeting 1994 Chairman, Multiple Myeloma/Lymphoma Session, American Society of

Hematology Annual Meeting 1996 Presenter, Non-Hodgkin’s Lymphoma Education Session, American Society

of Hematology Annual Meeting 1997 Presenter, Non-Hodgkin’s Lymphoma Education Session, American Society

of Clinical Oncology Annual Meeting 1997 Chairman, Emerging Issues in Managing Indolent Lymphomas, American

Society of Hematology Annual Meeting 1999 Presenter, Non-Hodgkin’s Lymphoma Education Session, American Society

of Clinical Oncology Annual Meeting 1999 Presenter, “Mantle Cell Lymphoma: Biology, Diagnosis and Management”, American Society of Hematology Education Session 1999 Presenter, “Treatment of Diffuse Aggressive Lymphomas”, Meet the Expert Session, American Society of Hematology Meeting 1999 Chairman, “Immunotherapy in Non-Hodgkin’s Lymphoma: New Treatment Advances”, American Society of Hematology Annual Meeting 2000 Chairman, “Lymphoma Therapy”, American Society of Hematology Annual

Meeting 2001 Chairman, “Lymphoma Therapy, Aggressive Lymphomas”, American

Society of Hematology Annual Meeting 2002 Coordinating Reviewer, Lymphoma Therapy,

American Society of Hematology Annual Meeting

9

2003 Chairman, United States/Japan Joint Summit on Lymphoma 2003 Presenter, FDA ODAC Meeting on Bexxar 2004 Chairman, Non-Hodgkin’s Lymphoma Education Session, American Society

of Hematology Annual Meeting 2007 Invited Discussant, Lymphoma Oral Session, American Society of Clinical Oncology EDITORIAL BOARD 1989-1992 Journal of Clinical Oncology 1990-1998 Journal of The National Cancer Institute 1992-1997 Journal of Biologic Response Modifiers (Journal of Immunotherapy) 1994-1997 Hematological Oncology 1999-2001 Journal of Clinical Oncology 2007-Present The Cancer Journal INVITED REVIEWER

New England Journal of Medicine Annals of Internal Medicine Journal of Clinical Oncology Blood Cancer Annals of Oncology Journal of Immunology Journal of Clinical Investigation Hematology/Oncology Annals Leukemia Clinical Cancer Research

HONORS AND AWARDS 1970 M.D. Cum Laude 1984 Fellow, American College of Physicians 1984 Outstanding Unit Citation for Studies of Diffuse Aggressive Lymphomas,

United States Public Health Service, Department of Health and Human Services

1985-Present Board of Governors, Southwest Oncology Group 1985-Present Chairman, Lymphoma Committee, Southwest Oncology Group 1988-1989 Chairman, Medical Research Advisory Group A, Veterans Administration 1988-1989 Program Committee, American Society of Clinical Oncology (Chairman,

Lymphomas, Leukemia, Pediatrics Section)

10

1988-1989 Board of Directors, American Society of Clinical Oncology 1989-1990 Chairman, Industry (Exhibits) Advisory Committee, American Society of

Clinical Oncology 1990 Visiting Professor, Cleveland Clinic 1990 Masters in Oncology Lecture Series, University of Wisconsin Cancer Center 1990-1991 Chairman, Young Investigator's Award Committee, American Society of

Clinical Oncology 1991 Paul Jackson Rogers Memorial Lectureship, Texas A & M University

College of Medicine 1991-2000 Chairman, External Advisory Committee, Prentis Comprehensive Cancer

Center, Michigan Cancer Foundation and Wayne State University 1992-Present The Best Cancer Specialists in the U.S.; Good Housekeeping Magazine 1993 Masters in Oncology Lecture Series, University of Wisconsin Cancer Center 1993 Bertha A. Bouroncle Keynote Lecture, The Ohio State University 1993-Present Director, Southwest Oncology Group Foundation 1995 Chairman, NIH Special Review Committee for AIDS-Associated

Malignancies Clinical Trial Consortium 1996- Present The Best Doctors in America 1996 Classic Paper: Highlights of Clinical Lymphoma Research (Reference

#157), Selected by Journal of Clinical Oncology 1997 Japanese Society of Lymphoreticular Malignancy Keynote Lecture 1997-2001 Member, NCI Scientific Review Group, Subcommittee H 1998-2001 Member, Board of Directors, Cure for Lymphoma Foundation 1999-Present The Best Doctors in America: Castle Connolly Medical Publications 1999-2001 External Advisory Board, Barrett Cancer Center, University of Cincinnati 2000-2005 Member, External Advisory Board, San Antonio Cancer Institute 2000-2001 Member, Lymphoma Research Foundation of America’s Honorary Medical

Board 2001-Present Member, Lymphoma Research Foundation Scientific Advisory Board

11

2000-2002 President, Faculty Senate, Loyola University Stritch School of Medicine 2001 Toni Thompson Memorial Lectureship in Oncology, University of Oklahoma, Oklahoma City, OK 2001 Derrick Crowther Lecturer, Cologne, Germany 2002 George P. Canellos Lecture in Medical Oncology, Dana Farber Cancer

Institute, Harvard 2002-2008 Board of Directors, Harvard Club of Rochester 2003-2005 Vice-President, Harvard Club of Rochester 2003 Honorary Chair, American Cancer Society Walter Hagen Golf Tournament 2004 Alan J. Underberg Lecture, University of Rochester 2005-2009 External Advisory Board, Yale University Cancer Center 2005-2007 President, Harvard Club of Rochester 2005 Grinberg/Wisch Endowed Visiting Lectureship in Hematology/Oncology,

Mount Sinai School of Medicine 2005-Present Vice President, Hope Foundation 2005-Present Deputy Group Chair, Southwest Oncology Group 2006 Davey Memorial Award for Outstanding Cancer Research, University of

Rochester Medical Center 2007-Present Member, University of Rochester Medical Center Board 2007 ASCO Statesman Award, American Society of Clinical Oncology 2008-Present Chair, Lymphoma Research Foundation Scientific Advisory Board 2009 Freundlich Leadership Award, Lymphoma Research Foundation 2010 Harold Amos Fellow, Harvard Medical School Dean’s Council RECENT INVITED LECTURES/PRESENTATIONS 1990 University of West Virginia, Charleston, VA.

Marshfield Clinic, Marshfield, WI. University of Pittsburgh, Pittsburgh, PA. Southwest Oncology Group Meeting, Denver, CO.

12

Porter Hospital, Denver, CO. University of Missouri, Kansas City, MO. European Association of Urology, 9th Congress, Amsterdam, NETHERLANDS Fourth International Conference on Malignant Lymphomas, Lugano, SWITZERLAND Cleveland Clinic, Cleveland, OH. Bronson Memorial Medical Center, Kalamazoo, MI. Evanston Hospital, Evanston, IL University of Wisconsin Cancer Center, Madison, WI. University of Rochester Cancer Center, Rochester, NY. University of Rochester Cancer Center, Rochester, NY. Carle Clinic, Urbana, IL. Cornell Medical Center, New York, NY. Southwest Oncology Group Meeting, Columbus, OH. Cook County Graduate School of Medicine, Chicago, IL. Northwest Community Hospital, Arlington Heights, IL. Fox Chase Cancer Center, Philadelphia, PA. George Washington University Board Review, Washington, DC. Winchester Medical Center, Winchester, VA. Interferon in the 90's: Decade of Decisions, Phoenix, AZ. International Cancer Update: Focus on Intron A, Cannes, FRANCE University of Pittsburgh Cancer Center, Pittsburgh, PA. Christ Hospital, Oak Lawn, IL. George Washington University Medical Center, Washington, DC.

1991 Bowman Gray Cancer Center, Winston-Salem, NC.

Texas A & M University College of Medicine, Temple, TX. Bleomycin Symposium, Miami, FL. Interferon Symposium, New Port Beach, CA. Georgetown University Cancer Center, Washington, DC. Cleveland Clinic, Cleveland, OH. American Society of Clinical Oncology, Houston, TX. International Congress of Chemotherapy, Berlin, GERMANY University of Pittsburgh Cancer Center, Pittsburgh, PA. Medical College of Wisconsin, Milwaukee, WI, University of Illinois, Chicago, IL. Cook County Hospital, Chicago, IL. Hodgkin's Disease Workshop, Cologne, GERMANY Southwest Oncology Group Meeting, Dearborn, MI. Mid-Atlantic Oncology Program, Greenbrier, West VA. American Society of Clinical Oncology, Miami, FL.

1992 FDA Biologics Advisory Board, Bethesda, MD.

Albert Einstein/Montefiore Hospital, New York, NY. M.D. Anderson Cancer Symposium, Orlando, FL. Southwest Oncology Group Meeting, San Antonio, TX. Cetus Oncology Division, San Francisco, CA. American Society of Clinical Oncology, San Diego, CA. Cowen & Company Investment Bankers, San Francisco, CA. Southwest Oncology Group Site Visit, Seattle, WA.

13

UCLA Symposium, Los Angeles, CA. Weiss Hospital Chicago, IL. Resurrection Hospital, Chicago, IL. Loyola University Alumni Educational Symposium, Chicago, IL. Oakwood Hospital, Detroit, MI. St. Joseph Hospital, South Bend, IN. Canadian Society for Clinical Investigation, Ottawa, CANADA St. Joseph Hospital, Chicago, IL. University of Nebraska, Omaha, NE. Cleveland Clinic, Cleveland, OH. Cook County Board Review, Chicago, IL. Southwest Oncology Group Meeting, St. Louis, MO. Episcopal Hospital, Philadelphia, PA. American Society of Hematology, Anaheim, CA. University of Arizona, Tucson, AZ.

1993 Duke University, Durham, NC.

University of Wisconsin, Madison, WI. Mt. Sinai Hospital, Miami Beach, FL. Illinois Masonic Medical Center, Chicago, IL. Scripp's Clinic, LaJolla, CA. Cedar Sinai Hospital, Los Angeles, CA. Loyola University Alumni Council, Chicago, IL. George Washington University, Washington, DC. Keystone Symposium, Copper Mountain, CO. Allegheny General Hospital, Pittsburgh, PA. American Society of Clinical Oncology, Orlando, FL. Third International Lymphoma Symposium, Lugano, SWITZERLAND Mt. Sinai Medical School, New York, NY. Cetus IL-2 Symposium, Colorado Springs, CO. Southern Oncology Association, St. Thomas, VIRGIN ISLANDS Non-Hodgkin's Lymphoma: Current Trends in Management Symposium, Colorado Springs, CO. Cook County Oncology Board Review, Chicago, IL. Harvard University Oncology Board Review, Boston, MA. German Lymphoma Society, Essen, GERMANY St. Bartholomew's Hospital, London, ENGLAND Memorial Hospital, South Bend, IN. Ohio State University, Columbus, OH.

Schering Oncology Division, Short Hills, NJ. American Cancer Society Clinical Trials Conference, Atlanta, GA. American Society of Clinical Oncology, Fall Conference, St. Louis, MO. Fort Meyers Medical Center, Fort Meyers, FL.

1994 University of Southern California, Los Angeles, CA.

Barnes Hospital, Washington University School of Medicine, St. Louis, MO Curriculum Development Roundtable in Interferons, Rancho Mirage, CA. Coleman Foundation Symposium, Chicago, IL. Gulf Cost Hematological Society, Houston, TX. Southwest Oncology Group Plenary Session, San Francisco, CA. Second International Meeting on High-Risk Hodgkin's Disease, Florence,

14

ITALY American Society of Clinical Oncology, Dallas, TX. Princess Margaret Hospital, Toronto, CANADA. Immunex Corporation Dose Intensification Experts' Retreat, Keystone, CO. Cancer Health Association, Merrillville, IN. Salick Health Care, Inc., Santa Monica, CA. Swedish Society of Hematology Meeting, Grisslehamn, SWEDEN Buffalo Blood Club, Buffalo, NY. The National Center for Advanced Medical Education: Specialty Review in Hematology, Chicago, IL. Methodist Hospital, Houston, TX. Blood Club, Houston, TX First Annual Oncology Update Conference, Ohio State University, Columbus, OH. Louisiana State University Medical Center, Shreveport, LA. James M. Pereleman Lectureship, Akron Cancer Center, Akron, OH.

1995 St. Vincent's Hospital, New York, NY.

The University of California-Irvine, Irvine, CA. Hoag Cancer Center, Newport Beach, CA. Case Western Reserve, Cleveland, OH. Deaconess Hospital, Spokane, WA. Scripps Clinic & Research Foundation, LaJolla, CA. State University of New York-Stony Brook, Stony Brook, NY. Montefiore Hospital, Pittsburgh, PA. James Graham Brown Cancer Center University of Louisville, KY. University of Chicago, Chicago, IL. Westchester Medical Center, Valhalla, NY. Seton Hospital, Austin, TX. Visiting Faculty In Interferons, Annenberg Cancer Center at Eisenhower Medical Center, Rancho Mirage, CA. 19th Inter-Congress of Chemotherapy, Montreal, Quebec, CANADA 9th Symposium on Molecular Biology of Hematopoiesis and Treatment of Leukemia and Lymphoma, Genoa, ITALY Pan-Pacific Lymphoma Conference, Maui, HAWAII University of Michigan Comprehensive Cancer Center, Ann Arbor, MI. Waukesha Memorial Hospital, Waukesha, WI. Columbia Presbyterian Hospital, New York, NY. 3rd International Symposium on Hodgkin's Lymphoma, Cologne,

GERMANY University of Chicago, Chicago, IL. The National Center for Advanced Medical Education: Specialty Review

in Hematology, Chicago, IL. Ottawa General Hospital, Ottawa, Ontario, CANADA Ottawa Blood Club, Ottawa, Ontario, CANADA St. Mary's Hospital, Richmond, VA. Dartmouth Hitchcock Medical Center, Lebanon, NH.

1996 Pharmacia Expert Panel Meeting, Houston, TX.

Sierra Medical Center, El Paso, TX. Winship Cancer Center at Emory University, Distinguished Investigators

15

Cancer Lectureship, Atlanta, GA. Pharmacy Visiting Faculty Update Meeting: Colony Stimulating Factors, San Francisco, CA. Non-Hodgkin's Lymphoma Consensus Conference, Phoenix, AZ. Clinical Implications of the R.E.A.L. Classification, Harvard University, Cambridge, MA. University of New Mexico, Albuquerque, NM. International Meeting, Foggia, ITALY Sixth International Conference on Malignant Lymphoma, Lugano, SWITZERLAND Licking County Memorial Hospital, Newark, OH. Marilyn Fixman Clinical Cancer Conference, Barnes Jewish Hospital, St. Louis, MO. AMGEN Visiting Faculty Retreat, San Francisco, CA University of Illinois Medical Center, Chicago, IL University of Virginia Health Sciences Center, Charlottesville, VA Marshfield Clinic, Marshfield, WI Schering Advisory Board Meeting, Boston, MA Medical Center of Delaware, Newark, DE West Suburban Hospital, Oak Park, IL. New York Cancer Society Scientific Program, New York, NY. James Graham Brown Cancer Center, Louisville, KY. University of California, Irvine Cancer Center, Orange, CA. Oregon Health Science Center, Portland, OR British Columbia Cancer Agency-Vancouver Center, Vancouver, BRITISH COLUMBIA AMGEN Visiting Professor, Sydney, Perth, Brisbane, Melbourne, AUSTRALIA Nagoya International Cancer Treatment Symposium, Nagoya, JAPAN Markey Cancer Center, Lexington, KY Lombardi Cancer Center, Georgetown, D.C.

1997 “Basic & Clinical Aspects of Lymphoma”, ASCO/AACR Joint Symposium,

Indian Wells, CA Memorial Sloan-Kettering, New York, NY Oregon Health Science Center, Portland, OR Scripps Clinic & Research Foundation, LaJolla, CA Blake Conference, Tucson, AZ University of Virginia, Williamsburg, VA Cleveland Clinic Foundation, Cleveland, OH Marshfield Clinic, Marshfield, WI St. Mary’s Hospital, Evansville, IN American Radium Society, New York, NY Manitoba Research Foundation, Winnipeg, CANADA “Frontiers of Malignant Hematology”, Toronto, CANADA 37TH Annual Meeting of Japanese Society of Lymphoreticular Tissue, Tokyo, JAPAN 20TH ICC Conference, Sydney, AUSTRALIA John Muir Medical Center, Walnut Creek, CA “Lymphoma. . . The next questions”, New Orleans, LA Advisory Board Meeting, Washington, D.C.

16

Medical College of Virginia, Richmond, VA ProED Communications Inc. Fellowship Program, Amelia Island, FL World Health Organization Meeting, Washington, D.C. American Society of Hematology Meetings, San Diego, CA

1998 University of Cincinnati Grand Rounds Lecture, Cincinnati, OH

Cleveland Clinic Foundation, Cleveland, OH Winter Oncology Conference - “Advances in Hematological

Malignancies”, Mont-Tremblant, CANADA 4TH International Hodgkin’s Symposium, Cologne, GERMANY B Cell Lymphoproliferative Disorders Conference, New York City, NY University of Indiana, Indianapolis, IN Manitoba Cancer Treatment & Research Foundation, Manitoba, CANADA University of Kentucky Markey Cancer Center, Lexington, KY 1998 Congress & Scientific Meeting of the Chinese Medical Association (Taipei), R.O.C., Taipei, CHINA 17th International Cancer Congress, Rio De Janeiro, BRAZIL Non-Hodgkin’s International Symposium, Munich, GERMANY World Health Organization Meeting, Bethesda, MD International Lymphoma Transplant Meeting, Lyon, FRANCE American Society of Clinical Oncology Meetings, Los Angeles, CA Markey Cancer Center, Lexington, KY “Hematologic Malignancies: The Next Question”, Chicago, IL George Washington University, Washington, D.C. Washington Cancer Center, Washington, D.C. George Washington University Tumor Board, Washington, D.C. Vanderbilt University, Nashville, TN All Chicago Fellows Conference, Chicago, IL “Education Network; Update 98 - Advances In Internal Medicine”, Chicago, IL West Suburban Hospital, Oak Park, IL “Lymphoma Think Tank Meeting”, San Diego, CA American Society of Hematology, Miami Beach, FL

1999 Oncology Conference, Kona, HI

University of Pennsylvania, Philadelphia, PA American Society of Clinical Oncology, Atlanta, GA International Conference on Malignant Lymphomas, Lugano, SWITZERLAND PAN Pacific Meeting, HAWAII Vanderbilt University, Nashville, TN Memorial Hospital of South Bend, South Bend, IN Brown University, Providence, RI NHL Advisory Meeting, London, ENG Memorial Sloan-Kettering, New York, NY “Congress of the SEOM (Sitges), Barcelona, ESP Second Annual Symposium, U.C. Davis Cancer Center, Sacramento, CA Dartmouth-Hitchcock Medical Center, Lebanon, NH Central Chapter of the Society of Nuclear Medicine, Oak Brook, IL Miami Valley Hospital, Dayton, OH University of Texas @ Southwestern Medical Center, Dallas, TX

17

St. Mary’s Hospital, Kankakee, IL Beth Israel Hospital, New York, NY New York State Society of Medical Oncology, New York, NY University of Texas, San Antonio, TX

2000 Second Annual Oncology Consensus Conference, Kailua-Kona, HI

Princess Margaret Hospital, Toronto, CA New England Medical Center, Boston, MA “Lymphoma Think Tank Meeting”, Stone Mountain, GA University of Iowa, Iowa City, IA Methodist Hospital, Memphis, TN Walter Reid Hospital, Washington, DC Chateau Frontenac, Quebec City, CA Hershey Medical Center, Hershey, PA Geisinger Medical Center, Danville, PA Washington Hospital, Washington, DC George Washington University, Washington, DC Cornell University, “Lymphoma/Myeloma 2000, New York City, NY University of Cincinnati Barrett Cancer Center, Cincinnati, OH Anne Arundel Medical Center, Annapolis, MD Dartmouth-Hitchcock Medical Center, Lebanon, NH

2001 Medicine Grand Rounds, Loyola University Medical Center, Maywood, IL

University of Colorado, Denver, CO National Medical Oncology Fellows Forum, Orlando, FL Washington University, St. Louis, MO 2nd Annual Post ASCO Review, Columbus, OH Pan Pacific Lymphoma Conference, Maui, HI St. Louis Oncology Society, St. Louis, MO Christian N.E. Medical Center, Clayton, MO Lineberger Cancer Center, University of North Carolina, Chapel Hill, NC International Symposium on Hodgkin’s Lymphoma, Cologne, GERMANY Hoag Cancer Center, Newport Beach, CA “Lymphoma the next questions”, Washington, DC Lymphoma Research Foundation, O’Hare Marriott, Chicago, IL Memorial Hospital, South Bend, IN

2002 Northwestern Oncology Consensus Conference, Kapalua Bay, Maui HI

Medicine Grand Rounds, University of Rochester, Rochester, NY Non-Hodgkin’s Lymphoma, Cowen Healthcare Panel, Boston, MA Pathology Seminar Series, University of Rochester, Rochester, NY Expanding Options: Treatment of Non-Hodgkin’s Lymphoma, Albany, NY Albany Medical Group, Grand Rounds, Albany, NY III International Conference on Malignant Lymphoma, Lugano, SWITZERLAND

Yale University Cancer Center, New Haven, CT Dana Farber Cancer Center, Harvard University, Cambridge, MA

2003 Taussig Cancer Center, Cleveland Clinic, Cleveland, OH St. Bartholomew’s Hospital, London, ENGLAND

18

University of Tennessee Medical Center, Memphis, TN Pan Pacific Lymphoma Conference, HI

First Opinion Leader's Summit, Northwestern University, HI NIAID Workshop on PTLD, Bethesda, MD Syracuse University Cancer Center, Syracuse, NY University of Washington Symposium, San Diego, CA

2004 University of Pittsburgh, Pittsburgh, PA

Allegheny General Hospital, Pittsburgh, PA Columbia University Cancer Center, NY Kimmel Cancer Center, Thomas Jefferson Medical College, Philadelphia, PA UCLA Cancer Center, Los Angeles, CA City of Hope Cancer Center, Duarte, CA University of South Carolina Cancer Center, Charleston, SC University of Oregon Cancer Center, Portland, OR German Hodgkin Lymphoma Meeting, Cologne, Germany Italian Lymphoma Conference, Palermo, Italy

2005 Leukemia Lymphoma Society Workshop, Washington, DC

Abbott Laboratories, Chicago, IL H. Lee Moffitt Cancer Center, Tampa, FL ASCO Board Review Session, Columbus, OH Forsythe Cancer Center, Winston-Salem, NC North Florida Regional Medical Center- Gainesville, FL Pan Pacific Lymphoma Conf/Kauai, HI Post Lugano 2005 Symposium, Georgetown University, DC St. Elizabeth's Medical Center, Boston, MA Southwest Oncology Group Plenary Session, Dallas, TX Inova Alexandria Hospital, Alexandria, VA Oncology World Congress, New York, NY

2007 Long Island Jewish Hospital, New York, NY

Cancer Institute of New Jersey California Oncology Society MD Anderson Cancer Center, Houston, TX Expert Workshop, Munich, Germany V Foundation Award Dinner, New York, NY Hematology Symposium, Tokyo, Japan International T-Cell Lymphoma Workshop, Chicago, IL University of California, San Diego Great Debates in Hematology, Colorado Springs, CO Lymphoma & Myeloma 2006, New York, NY Chemotherapy Foundation Symposium, New York, NY

2007 Case Western Reserve University, Cleveland, Ohio

19

University of Nebraska, Omaha, Nebraska Karmanos Cancer Center, Wayne State University, Detroit, Michigan University of Texas, San Antonio, Texas Follicular Lymphoma Workshop, Scotland Roswell Park Cancer Center, Buffalo, NY MD Anderson Cancer Center, Orlando, FL Oncology Nurses Society National Meeting, Las Vegas, NV MabThera International Advisory Board, Riga, Latvia 2008 City of Hope, Duarte, CA; Kauai, HI

Hoag Cancer Center, Newport Beach, CA Thomas Jefferson University, Philadelphia, PA International Japanese Hematology Conference, Tokyo Japan Taussig Cancer Institute, Cleveland, OH Maimonides Comprehensive Cancer Center, New York, NY Sylvester Cancer Center, Miami, FL Southern California Oncology Society, Marina delRay, CA Albany Oncology Society, Albany, NY ASH Highlights, Chicago, IL European Society of Oncology, Ascona Switzerland International Lymphoma Conference, Lugano, Switzerland ASCO Review, Columbus, OH University of Pittsburgh Grand Rounds, Beaver, PA Memphis Cancer Center, Memphis, TN Georgetown University Cancer Center, Washington, DC

2009 Forsythe Medical Center, Winston-Salem, NC

City of Hope Lymphoma Meeting, Kauai, HI University of Texas Health Science Center, San Antonio, TX Michigan State Cancer Center, East Lansing, MI Dana Farber Harvard Cancer Course, Boston, MA Columbus CCOP ASCO Review, Columbus, OH Pan Pacific Lymphoma Conference, HI NCI SWOG Site Visit, Bethesda, MD Karmanos Cancer Center, Detroit, MI German Lymphoma Think Tank, Bonn, Germany

HEALTHCARE MANAGEMENT SYMPOSIUMS/COURSES ATTENDED 1997 Symposium on Integrated Healthcare

1997 Physicians in Management Seminar I, American College of Physician Executives 1999 Symposium on Integrated Healthcare 1999 Physician in Management Seminar II, American College of Physician Executives 2000 Physician Management Certificate Program, Executive Management Program, Loyola University Chicago School of Business Administration EXTRAMURAL GRANT AND CONTRACT SUPPORT:

20

1984-1985 NCI-CM-37613-64

"Phase I Clinical Trial of Natural and Recombinant Interleukin 2" Loyola Contract, #125,000.

Co-Investigator (Stephen P. Creekmore, M.D., Ph.D., Principal Investigator)

1986-1987 NCI-CA 32102-06

"Phase II Study of IL-2/LAK in Metastatic Cancer"

$597,323.

Principal Investigator 1987-1991 NO1-CM-73704

"Clinical Trials of Activated Leukocytes"

$2,723,391.

Principal Investigator 1988-1993 1U10 CA46282-01

"Southwest Oncology Group Institutional Grant"

$671,000.

Principal Investigator 1988-1993 Bristol-Myers and National Cancer Institute

"Tumor Resistance to Chemotherapy"

$1,000,000.

Principal Investigator

1989-1992 1-RO1-CA48069

"Differentiation and Heterogeneity of Human LAK Cells"

$420,925.

Co-Investigator (Thomas M. Ellis, Ph.D., Principal Investigator)

21

1991-1994 1-RO1-CA 55509-01

"Biology and Treatment of AIDS Lymphomas"

$543,159.

Principal Investigator 1993-1998 2-U10-CA46282-06

Southwest Oncology Group Grant/Loyola University $1,200,000.


1998-2002 2U10-CA46282-06

Southwest Oncology Group Grant/Loyola University $2,102,704.


1998-2003 1-P20-CA79403-01

Cancer Center Planning Grant

$1,385,629. Principal Investigator

2001-2006 NO1-CM-17102-1

NCI-Phase II Contract

Approximately $750,000. Co-Investigator: (Everett C. Vokes, M.D., Univ. of Chicago, Principal Investigator)

2002-2005 5U10-CA11083-34

Southwest Oncology Group Grant/University of Rochester

$1,526,846


22

2004-2009 2U10-CA011083-37 (37-42) Southwest Oncology Group Grant/University of Rochester $2,543,221 Principal Investigator 2004-2005 C76 HF02940-01-00 (DHHS/PHS/HRSA) Equipment Grant/James P. Wilmot Cancer Center $984,159 Principal Investigator 2005 - 2009 5U10 CA 32102 Southwest Oncology Group Lymphoma Committee Chair

$250,000 Principal Investigator

2005 - 2009 5U10 CA 32102 Southwest Oncology Group Deputy Group Chair

$85,000 Principal Investigator

2006-2008 DE-FG02-06CH11430 (DOE) Equipment Grant/James P. Wilmot Cancer Center $962,000 Principal Investigator 2007-2012 W81XWH0710601 (DOD) Early Diagnosis, Treatment and Care of Cancer Patients $4,287,000 Principal Investigator 2008-2013 1P50CA130805-01A1

23

Lymphoma SPORE $11,500,000 Principal Investigator IMPACT OF PUBLICATIONS: Dr. Fisher’s publications have been cited 15,594 times from 1984-2006. Most common publications cited include: 1. Reference #161 cited 1348 times from 1993-2006

Shipp, M.A., Harrington, D.P., Anderson, J.R., Armitage, J.O., Bonnadonna, G., Brittinger, G., Cabanillas, F., Canellos, G.P., Coiffer, B., Connors, J.M., Cowan, R.A., Crowther, D., Dahlberg, S.J., Engelhard, M., Fisher, R.I., Insselbrecht, C., Horning, S.J., Lepage, E., Lister, A., Meerwaldt, J.H., Montserrat, E., Nissen, N.I., Oken, M.M., Peterson, B.A., Tondini, C., Velasquez, W.S., and Yeap, B.Y: Development of a predictive model for aggressive lymphoma: The international non-Hodgkin's lymphoma prognostic factors project. N. Engl. J. Med. 329:987-994, 1993

2. Reference #159 cited 951 times from 1993-2006

Fisher, R.I., Gaynor, E.R., Dahlberg, S., Oken, M.M., Grogan, T.M., Mize, E.M., Glick, J.H., Coltman, C.A., and Miller, T.P.: Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N. Engl. J. Med. 328:1002-1006, 1993.

3. Reference #133 cited 603 times from 1990-2006

Swinnen, L.J., Costanzo-Nordin, M.R., Fisher, S.G., O'Sullivan, E.J., Johnson, M.R., Heroux, A.L., Dizikes, G.J., Pifarre, R., and Fisher, R.I.: Increased incidence of lymphoproliferative disorders following immunosuppression with OKT3 in cardiac transplantation. N. Engl. J. Med. 323:1723-1728, 1990.

4. Reference # 236 cited 568 times from 1999 to 2006 Cheson, B.D., Horning, S.J., Coiffer, B., Shipp, M.A., Fisher, R.I., Connors, J.M., Lister,

T.A.,Vose, J., Grillo-Lopez, A., Hagenbeek, A., Cabanillas, F., Castellino, R., Hiddeman, W.,Klippenstein, D., Harris, N.L., Armitage, J.E., Carter, W., Hoppe, R., and Canellos, G.P.: Report of an International Workshop to standardize response criteria for non-Hodgkin’s lymphoma. J. Clin.Oncol. 12:1244-1253, 1999.

5. Reference # 261 cited 540 times from 2002 to 2006

Rosenwald, A., Wright, G., Chan, W.C., Connors, J.M., Campo, E., Fisher, R.I., Gascoyne,

24

R.N., Konrad Muller-Hermeliuk, H., Smeland, E.R., and Staudt, L.M. The use of molecular profiling to predict survival after chemotherapy of diffuse large B-cell lymphomas. N. Engl. J. Med. 346:1937-1947, 2002.


Fisher, R.I., DeVita, V.T., Hubbard, S.M., Longo, D.L., Wesley, R., Chabner, B.A., and Young, R.C.: Diffuse aggressive lymphomas: increased survival after alternating flexible sequences of ProMACE and MOPP chemotherapy. Ann. Intern. Med. 98:304-309, 1983.


Young, R.C., Chabner, B.A., Hubbard, S.P., Fisher, R.I., Bender, R.A., Anderson, T., Simon, R.M., Canellos, G.P., and DeVita, V.T.: Advanced ovarian adenocarcinoma: a prospective clinical trial of Melphalan (L-PAM) va. combination chemotherapy (Hexa-CAF). N. Engl. J. Med. 299:1261-1266, 1978.

8. Reference # 98 cited 330 times from 1988 to 2006 Fisher, R.I., Coltman, C.A., Doroshow, J.A., Rayner, A.A., Hawkins, M.J., Mier, J.W.,

Wiernik, P., McMannis, J.D., Weiss, G.R., Margolin, K.A., Gemlo, B.T., Hoth, D.T., Parkinson, D.R., and Paietta, E.: A Phase II clinical trial of Interleukin-2 and Lymphokine Activated Killer Cells (LAK) in metastatic renal cancer. Ann. Intern. Med. 108:518-523, 1988.


Miller, T.P., Dahlberg, S., Cassady, J.R., Adelstein,, D.J., Spier, C.M., Grogan, T.M., LeBlanc, M., Carlin, S., Chase, E., and Fisher, R.I.: A randomized trial comparing chemotherapy alone to chemotherapy followed by radiotherapy for localized intermediate and high grade non-Hodgkin’s lymphoma. N. Engl. J. Med. 339:21-25, 1998.


Fyfe, G., Fisher, R.I., Rosenberg, S.A., Sznol, M., Parkinson, D.R., and Louie, A.C. Results of treatment of 255 patients with metastatic renal carcinoma who received high dose Proleukin recombinant interleukin-2 therapy. J. Clin. Oncol. 13:688-697, 1995.

11. Reference #208 cited 202 times from 1995 to 2006

Fisher, R.I., Dahlberg, S., Nathwani, B.N., Banks, P.M., Miller, T.P., and Grogan, T.M. A clinical analysis of two indolent lymphoma entities: mantle cell lymphoma and marginal zone lymphoma (including the MALT and monocytoid B subcategories). A Southwest Oncology Group Study. Blood. 85:1075-1082, 1995.

Date post:	14-Feb-2017
Category:	Documents
Upload:	buique
View:	217 times
Download:	2 times

1 September 2010 CURRICULUM VITAE NAME: Richard I. Fisher ...

Documents